Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1998-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM9801915PMID 9719599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.

  1998cited by this paper
• 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.

  1998cited by this paper
• Physiological action of progesterone in target tissues.

  1997cited by this paper
• Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.

  1996cited by this paper
• Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail.

  1996cited by this paper
• Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.

  1995cited by this paper
• Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors.

  1995cited by this paper
• Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6-tetrahydropyridazines.

  1995cited by this paper
• Intracellular receptors and signal transducers and activators of transcription superfamilies: novel targets for small-molecule drug discovery.

  1995cited by this paper
• History and perspectives of antiprogestins from the chemist's point of view.

  1994cited by this paper
• The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells

  1994cited by this paper
• Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription.

  1994cited by this paper
• Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.

  1993cited by this paper
• Nuclear Hormone Receptors as Targets for New Drug Discovery

  1993cited by this paper
• Interaction of glucocorticoid analogues with the human glucocorticoid receptor.

  1992cited by this paper
• Effects of progesterone antagonists RU486 and ZK98734 on embryo transport, development and implantation in laboratory mice.

  1990cited by this paper
• New steroids with antiprogestational and antiglucocorticoid activities.

  1984cited by this paper
• Binding of progesterone and R 5020, a highly potent progestin, to human endometrium and myometrium.

  1974cited by this paper

• Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.

  2024cites this paper
• Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity

  2020cites this paper
• Appendix A. dithioloquinolinethiones as new potential multitargeted antibacterial and antifungal agents: Synthesis, biological evaluation and molecular docking studies.

  2019cites this paper
• Green synthesis of TiO 2 nanoparticles as an efficient heterogeneous catalyst with high reusability for synthesis of 1,2‐dihydroquinoline derivatives

  2019cites this paper
• Current Progresses and Trends in the Development of Progesterone Receptor Modulators.

  2016cites this paper
• Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists.

  2015cites this paper
• Highly efficient synthesis of polysubstituted 1,2-dihydroquinolines via tandem reaction of α-ketoesters and arylamines catalyzed by fluorous hydrazine-1,2-bis(carbothioate) and NCS

  2013cites this paper
• Receptor-based QSAR study for a series of 3 , 3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors

  2011cites this paper
• Highly Efficient Synthesis of Polysubstituted 1,2-Dihydroquinolines via Tandem Reaction of α-Ketoesters and Arylamines Catalyzed by Indium Triflate

  2011cites this paper
• Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors

  2011cites this paper
• 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.

  2011cites this paper
• Structural basis for computational screening of non-steroidal androgen receptor ligands

  2010cites this paper
• Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.

  2008cites this paper
• Progesterone Receptor: Overview of Modern Steroidal Progestins and Developments in the Field of Nonsteroidal Selective Progesterone Receptor Modulators

  2008cites this paper
• Potent, selective MCH-1 receptor antagonists.

  2008cites this paper
• Discovery of structurally diverse nonsteroidal SPRMs based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.

  2008cites this paper
• Facile Synthesis of 3,3‐Dialkyl‐6‐phenyl‐imidazopyridinones

  2007cites this paper
• The evolution of progesterone receptor ligands

  2007cites this paper
• Antioxidant profile of ethoxyquin and some of its S, Se, and Te analogues.

  2007cites this paper
• Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.

  2006cites this paper
• Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.

  2006cites this paper
• Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands.

  2006cites this paper
• Nonsteroidal progesterone receptor ligands (II); synthesis and SAR of new tetrahydrobenzindolone derivatives.

  2006cites this paper
• Synthesis of trisubstituted thiophenes designed as progesterone receptor modulator

  2006cites this paper
• Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.

  2006cites this paper
• Synthesis of 4,4‐Disubstituted‐4H‐benzo[d][1,3]oxathiin‐2‐ones, a New Class of Compounds

  2006cites this paper
• Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships

  2005cites this paper
• Nonsteroidal progesterone receptor modulators: structure activity relationships.

  2005cites this paper
• SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists.

  2005cites this paper
• Non-steroidal steroid receptor modulators.

  2005cites this paper
• Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore.

  2003cites this paper
• The pursuit of differentiated ligands for the glucocorticoid receptor.

  2003cites this paper
• Novel strategies for the solid phase synthesis of substituted indolines and indoles.

  2003cites this paper
• Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators.

  2003cites this paper
• New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles.

  2002cites this paper
• In vitro and in vivo characterization of novel nonsteroidal progesterone receptor antagonists derived from the fungal metabolite PF1092C.

  2002cites this paper
• Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.

  2002cites this paper
• Chapter 17. Selective glucocorticoid receptor modulators

  2002cites this paper
• Mechanism of Action of Progesterone Antagonists

  2002cites this paper
• 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.

  2002cites this paper
• Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones.

  2001cites this paper
• Fungal metabolites, PF1092 compounds and their derivatives, are nonsteroidal and selective progesterone receptor modulators.

  2001cites this paper
• Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines.

  2000cites this paper
• Preclinical experience with two selective progesterone receptor modulators on breast and endometrium.

  2000cites this paper
• Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.

  2000cites this paper
• Novel class of non-steroidal progesterone receptor antagonists

  1999cites this paper
• Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071).

  1999cites this paper
• 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.

  1999cites this paper
• Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.

  1999cites this paper
• Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines.

  1998cites this paper